Aruba Health Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Health Monitor.

Press releases published on November 11, 2026

6 hours ago

NRx Pharmaceuticals Begins Selling U.S.-Made, Preservative-Free Ketamine Amid Long-Running Shortage

Indeterminate GlobeNewswire

6 hours ago

Nurix Therapeutics Appoints Arati V. Rao, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

6 hours ago

Hemab Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey Club

Indeterminate GlobeNewswire

6 hours ago

Sinaptica Therapeutics to Host Scientific Symposium at CTAD 2026 Exploring the Role of Brain Network Dysfunction in Alzheimer's Disease

Indeterminate GlobeNewswire

6 hours ago

Nkarta Presents Initial Safety Data for NKX019 in 40 Patients Across Five Autoimmune Diseases at ACR Convergence 2026

Indeterminate GlobeNewswire

6 hours ago

CDT Commences Human Skin Studies with QIMA Life Sciences on Novel Tapinarof Combinations in Vitiligo

Indeterminate GlobeNewswire

7 hours ago

The savings that cost more: new report puts a number on Europe's innovation choice

Indeterminate GlobeNewswire

7 hours ago

64% of NMN Supplements Failed Independent Purity Testing: Element 5 Publishes Every Batch Report for Its Own

Indeterminate GlobeNewswire

9 hours ago

New Kidney International Study Provides Preclinical Proof-of-Concept for TolerogenixX’s MIC Platform in Lupus Nephritis

Indeterminate GlobeNewswire

11 hours ago

Devia Emerges from Stealth with an Agentic AI for GxP Pharma Quality Management

Indeterminate GlobeNewswire

14 hours ago

Onco-Innovations Announces Agreement to Terminate Performance-Based Funding Arrangement with Sorbie

Indeterminate GlobeNewswire

14 hours ago

Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock

Indeterminate GlobeNewswire

15 hours ago

Prime Medicine Announces Pricing of Public Offering of Common Stock

Indeterminate GlobeNewswire

17 hours ago

AGCバイオロジクス、チャイルズ・キュア・ジネティック・リサーチと提携し、重度のてんかん性疾患に対するmRNAベースの治療薬の開発に取り組む

Indeterminate GlobeNewswire

17 hours ago

AGC 바이오로직스, 차일즈 큐어 유전연구재단과 협력해 중증 뇌전증 질환 치료 위한 mRNA 기반 치료제 개발 추진

Indeterminate GlobeNewswire

17 hours ago

AGC Biologics bekerjasama dengan Child’s Cure Genetic Research untuk membangunkan terapi berasaskan mRNA bagi merawat gangguan epilepsi yang teruk

Indeterminate GlobeNewswire

17 hours ago

AGC Biologics 与 Child’s Cure Genetic Research 合作开发针对严重癫痫性疾病的 mRNA 疗法

Indeterminate GlobeNewswire

17 hours ago

AGC Biologics 與 Child’s Cure Genetic Research 攜手研發針對嚴重癲癇疾病的 mRNA 療法

Indeterminate GlobeNewswire